Search

MSK researchers recently reported results of a phase 2 trial for GIST, a rare form of gastrointestinal cancer. The trial was based on years of lab work conducted by physician-scientist Ping Chi.

… Friday, February 11, 2022 When Luis Portiansky had his first surgery in 1993 for a rare form of cancer that developed in his stomach, Ping Chi was still an undergraduate student at Mount Holyoke College in Massachusetts. More than two decades later, when Luis’ cancer came back for the third time, Dr.

MSK was recently in the news regarding our relationship with a technology spin-off company called Paige.AI.

… Sunday, September 23, 2018 MSK was recently in the news regarding our relationship with a technology spin-off company called Paige.AI. The MSK board and leadership believe that this pioneering work has the potential to improve the diagnosis and care of cancer patients around the world. MSK is proud to

MSK achieved status as a Magnet®-recognized organization, an esteemed honor for nursing excellence.

… Wednesday, February 17, 2016 Summary The American Nurses Credentialing Center granted Magnet recognition ® to MSK today, a prestigious honor given to institutions that demonstrate nursing excellence. This achievement confirms the superb performance of the entire nursing staff and marks the culmination

Find out how to handle feelings of self-blame and shame that may accompany a cancer diagnosis.

… Wednesday, October 9, 2019 Summary Many people experience self-blame around a cancer diagnosis, and some may even experience feelings of embarrassment or shame. There are ways around that, says MSK social worker Kristie Redfield. Having cancer is difficult. Adding feelings of guilt, shame, or embarrassment

Worry and confusion around COVID-19 are common in the general population, but cancer patients are also balancing concern over what the pandemic means for their treatment, prognosis, and vulnerability to the virus.

… Tuesday, May 5, 2020 Worry and confusion around COVID-19 are common in the general population, but cancer patients are also balancing concern over what the pandemic means for their treatment, prognosis, and vulnerability to the virus. Doctors and nurses at Memorial Sloan Kettering (MSK) shared their

A study by Memorial Sloan Kettering (MSK) recently published in JAMA Oncology showed that radiation dose to the elective regions can be safely de-escalated for patients with human papillomavirus (HPV)-associated oropharyngeal cancer (OPC) who received concurrent chemotherapy.

… Thursday, March 10, 2022 A study by Memorial Sloan Kettering (MSK) recently published in JAMA Oncology   (1) showed that radiation dose to the elective regions can be safely de-escalated for patients with human papillomavirus (HPV)-associated oropharyngeal cancer (OPC) who received concurrent chemotherapy

Leaders from both institutions announced their collaboration and shared details about what it can mean for people with cancer in the state and throughout the world.

… Wednesday, December 14, 2016 Executives at Memorial Sloan Kettering and Hackensack Meridian Health announce a partnership at a press conference Dr. Sergio Giralt (left), Chief of Memorial Sloan Kettering's Adult Bone Marrow Transplant Service and Melvin Berlin Family Chair in Multiple Myeloma, and Dr

Memorial Sloan Kettering investigators hope their new web tool will improve the accessibility of large-scale genome-sequencing information for cancer researchers everywhere, and accelerate research and therapeutic discovery.

… Thursday, June 21, 2012 Summary Memorial Sloan Kettering investigators hope their new web tool will improve the accessibility of large-scale genome-sequencing information for cancer researchers everywhere, and accelerate research and therapeutic discovery. Scientists at Memorial Sloan Kettering have

Find out what Memorial Sloan Kettering experts recommend when it comes to marijuana, CBD, and other forms of cannabis for cancer.

… Tuesday, June 15, 2021 New York State is the latest to legalize the recreational use of marijuana for adults. We asked Nirupa Raghunathan , an integrative medicine doctor at Memorial Sloan Kettering, and pharmacist Jason Hou, who manages MSK’s About Herbs database, to share what people with cancer should

The new cells, which the scientists have dubbed killer innate-like T cells, differ in several notable ways from the conventional target of many immunotherapies.

… Wednesday, April 20, 2022 Despite the success of immunotherapy in helping many people with cancer, the majority of patients still do not respond to these treatments. There is need for continued research. On April 20, 2022, researchers at the Sloan Kettering Institute reported in the journal Nature that